March 15, 2021
Via: CNBCGenMark Diagnostics (GNMK) – GenMark will be bought by Swiss drugmaker Roche for $1.8 billion in cash, or $24.05 per share. Shares of the U.S.-based molecular diagnostic test maker had closed at $18.50 per share on Friday. GenMark surged 29.2% […]
September 28, 2023
September 21, 2023
September 19, 2023
September 21, 2023
September 25, 2023
September 25, 2023
September 25, 2023
September 27, 2023